These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 12098091

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Epitope specificity and inactivation mechanisms of factor VIII inhibitor antibodies.
    Scandella D.
    Vox Sang; 1999; 77 Suppl 1():17-20. PubMed ID: 10529680
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Epitope specificity of anti-factor VIII antibodies from inhibitor positive acquired and congenital haemophilia A patients using synthetic peptides spanning A and C domains.
    Gharagozlou S, Sharifian RA, Khoshnoodi J, Karimi K, Milani M, Okita DK, Shokri F, Conti-Fine BM.
    Thromb Haemost; 2009 May; 101(5):834-9. PubMed ID: 19404535
    [Abstract] [Full Text] [Related]

  • 7. Some human inhibitor antibodies interfere with factor VIII binding to factor IX.
    Zhong D, Saenko EL, Shima M, Felch M, Scandella D.
    Blood; 1998 Jul 01; 92(1):136-42. PubMed ID: 9639509
    [Abstract] [Full Text] [Related]

  • 8. Molecular characterization of the immune response to factor VIII.
    Lollar P.
    Vox Sang; 2002 Aug 01; 83 Suppl 1():403-8. PubMed ID: 12617176
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Reduction of the inhibitory antibody response to human factor VIII in hemophilia A mice by mutagenesis of the A2 domain B-cell epitope.
    Parker ET, Healey JF, Barrow RT, Craddock HN, Lollar P.
    Blood; 2004 Aug 01; 104(3):704-10. PubMed ID: 15073030
    [Abstract] [Full Text] [Related]

  • 14. The inhibitor antibody response is more complex in hemophilia A patients than in most nonhemophiliacs with factor VIII autoantibodies. Recombinate and Kogenate Study Groups.
    Prescott R, Nakai H, Saenko EL, Scharrer I, Nilsson IM, Humphries JE, Hurst D, Bray G, Scandella D.
    Blood; 1997 May 15; 89(10):3663-71. PubMed ID: 9160671
    [Abstract] [Full Text] [Related]

  • 15. Localization of epitopes for human factor VIII inhibitor antibodies by immunoblotting and antibody neutralization.
    Scandella D, Mattingly M, de Graaf S, Fulcher CA.
    Blood; 1989 Oct 15; 74(5):1618-26. PubMed ID: 2477082
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Antigenicity of putative phospholipid membrane-binding residues in factor VIII.
    Barrow RT, Healey JF, Jacquemin MG, Saint-Remy JM, Lollar P.
    Blood; 2001 Jan 01; 97(1):169-74. PubMed ID: 11133757
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Different factor VIII neutralizing effects on anti-factor VIII inhibitor antibodies associated with epitope specificity and von Willebrand factor.
    Yada K, Nogami K, Shima M.
    Br J Haematol; 2013 Oct 01; 163(1):104-11. PubMed ID: 23889549
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.